SGMO | Sangamo Therapeutics
Category: Biotechnology company
Quick infos Headquarters: Richmond, California, United States Trade prices Volume: Market Cap: 1.87B Prev closed: 9.42 Open: 9.66 High: 9.66 Low: 8.69 52 week low: 4.81 52 week high: 13.33 Dividends: No Dividends Next ER: February 24, 2021 After Market Closes
About the Company Sangamo Therapeutics, Inc. is an American biotechnology company based in Richmond, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases.
Earnings History Date EPS / Forecast Revenue / Forecast May 12, 2021 February 24, 2021 -0.29 / -0.212725.8M / 31.42MNovember 4, 2020 -0.01 / -0.24257.76M / 26.55MBeat! August 5, 2020 -0.26 / 0.1121.55M / 102.71MBeat! May 11, 2020 -0.37 / -0.2813.08M / 22.74Mview more
Historical Data Date Price Open High Low Vol Change ER Feb 26, 2021 11.49 11.32 11.76
11.19
3.35M 2.68% Feb 25, 2021 11.19 12.12 12.70
11.19
2.20M -10.62% Feb 24, 2021 12.52 12.58 12.68
12.08
1.09M 1.54% Feb 23, 2021 12.33 12.05 12.78
11.66
1.83M -2.3% Feb 22, 2021 12.62 13.15 13.15
12.58
1.31M -4.47% Feb 19, 2021 13.21 13.44 13.73
13.00
1.31M -1.56% Feb 18, 2021 13.42 13.21 13.48
12.86
1.24M -0.22% Feb 17, 2021 13.45 13.30 13.52
12.94
1.18M -0.44% Feb 16, 2021 13.51 13.67 13.67
13.13
1.85M -1.24% Feb 12, 2021 13.68 13.75 13.95
13.48
1.11M -1.3% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US8006771062 CUSIP: 800677106 Founded:1995 Employees:131 News
First Week of SGMO August 2021 Options Trading nasdaq.com Dec 18, 2020 2:12 pm
Are Options Traders Betting on a Big Move in Sangamo Therapeutics (SGMO) Stock? finance.yahoo.com Dec 14, 2020 12:12 pm Pfizer, Sangamo gene therapy for hemophilia shows sustained factor VII activity seekingalpha.com Dec 7, 2020 8:31 pm
SGMO Crosses Below Key Moving Average Level nasdaq.com Dec 7, 2020 4:12 pm
Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels in 3x1013 VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy finance.yahoo.com Dec 7, 2020 11:12 am
Pfizer, Sangamo Report Encouraging Findings From Phase 1/2 Study Of Giroctocogene Fitelparvovec nasdaq.com Dec 7, 2020 11:12 am
How Much Did Sangamo Therapeutics'(NASDAQ:SGMO) Shareholders Earn From Share Price Movements Over The Last Three Years? finance.yahoo.com Nov 30, 2020 4:11 pm Sangamo Therapeutics, Inc. to Host Earnings Call marketwatch.com Nov 6, 2020 10:11 pm Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q3 2020 Results - Earnings Call Transcript seekingalpha.com Nov 5, 2020 1:11 am Sangamo Therapeutics Inc (SGMO) Q3 2020 Earnings Call Transcript fool.com Nov 4, 2020 11:11 pm Sangamo Therapeutics EPS beats by $0.24, beats on revenue seekingalpha.com Nov 4, 2020 8:11 pm Sangamo Therapeutics Q3 2020 Earnings Preview seekingalpha.com Nov 3, 2020 11:11 pm CRISPR startup Scribe Therapeutics lands big Biogen deal bizjournals.com Oct 6, 2020 8:10 pm This company doesn't provide a dividend.
Key Persons CEO : Alexander Macrae, PhD Talk about Sangamo Therapeutics below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Homepage: sangamo.com Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.
A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology
